262 related articles for article (PubMed ID: 31049937)
1. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
3. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
4. Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma.
Riihilä P; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Grénman R; Peltonen S; Peltonen J; Pihlajaniemi T; Heljasvaara R; Kähäri VM
Am J Pathol; 2017 May; 187(5):1186-1197. PubMed ID: 28322200
[TBL] [Abstract][Full Text] [Related]
5. Complement factor I promotes progression of cutaneous squamous cell carcinoma.
Riihilä P; Nissinen L; Farshchian M; Kivisaari A; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2015 Feb; 135(2):579-588. PubMed ID: 25184960
[TBL] [Abstract][Full Text] [Related]
6. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
7. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
[TBL] [Abstract][Full Text] [Related]
9. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
11. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
12. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
13. Tumour serine proteases C1r and C1s as novel biomarkers and therapeutic targets in invasive sporadic and recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma.
Kopecki Z
Br J Dermatol; 2020 Mar; 182(3):530-531. PubMed ID: 31486079
[No Abstract] [Full Text] [Related]
14. Expression of claudin-11 by tumor cells in cutaneous squamous cell carcinoma is dependent on the activity of p38δ.
Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Farshchian M; Kivisaari A; Kallajoki M; Raiko L; Peltonen J; Peltonen S; Kähäri VM
Exp Dermatol; 2017 Sep; 26(9):771-777. PubMed ID: 27992079
[TBL] [Abstract][Full Text] [Related]
15. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
[TBL] [Abstract][Full Text] [Related]
16. The Genomic Landscape of Actinic Keratosis.
Thomson J; Bewicke-Copley F; Anene CA; Gulati A; Nagano A; Purdie K; Inman GJ; Proby CM; Leigh IM; Harwood CA; Wang J
J Invest Dermatol; 2021 Jul; 141(7):1664-1674.e7. PubMed ID: 33482222
[TBL] [Abstract][Full Text] [Related]
17. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
18. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.
Lambert SR; Mladkova N; Gulati A; Hamoudi R; Purdie K; Cerio R; Leigh I; Proby C; Harwood CA
Br J Cancer; 2014 Jan; 110(2):520-9. PubMed ID: 24335922
[TBL] [Abstract][Full Text] [Related]
19. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
Fan Z; Qin J; Wang D; Geng S
J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA plasmacytoma variant translocation 1 is overexpressed in cutaneous squamous cell carcinoma and exon 2 is critical for its oncogenicity.
Li C; Sun C; Mahapatra KD; Riihilä P; Knuutila J; Nissinen L; Lapins J; Kähäri VM; Homey B; Sonkoly E; Pivarcsi A
Br J Dermatol; 2024 Feb; 190(3):415-426. PubMed ID: 37930852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
